bupranolol has been researched along with 2-pyrrolidone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babu, RJ; Dhanasekaran, M; Pandit, JK; Singh, PN; Vaithiyalingam, SR | 1 |
1 other study(ies) available for bupranolol and 2-pyrrolidone
Article | Year |
---|---|
Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Animals; Area Under Curve; beta-Cyclodextrins; Bupranolol; Drug Antagonism; Drug Delivery Systems; Female; Heart Rate; Injections, Intravenous; Isoproterenol; Male; Permeability; Pyrrolidinones; Rabbits; Skin; Skin Absorption; Tachycardia | 2008 |